These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 23110790)

  • 1. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.
    Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):808-18. PubMed ID: 23110790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
    Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS
    JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Yan J; Liu M; Yang D; Zhang Y; An F
    Cardiovasc Drugs Ther; 2024 Aug; 38(4):799-817. PubMed ID: 36103100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
    Aung T; Halsey J; Kromhout D; Gerstein HC; Marchioli R; Tavazzi L; Geleijnse JM; Rauch B; Ness A; Galan P; Chew EY; Bosch J; Collins R; Lewington S; Armitage J; Clarke R;
    JAMA Cardiol; 2018 Mar; 3(3):225-234. PubMed ID: 29387889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
    Marik PE; Varon J
    Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids and cardiovascular risk.
    Kruse LG; Ogletree RL
    J Miss State Med Assoc; 2013 Jun; 54(6):156-7. PubMed ID: 23991511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials.
    Saglimbene VM; Wong G; van Zwieten A; Palmer SC; Ruospo M; Natale P; Campbell K; Teixeira-Pinto A; Craig JC; Strippoli GFM
    Clin Nutr; 2020 Feb; 39(2):358-368. PubMed ID: 30905498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].
    Casula M; Soranna D; Catapano AL; Corrao G
    Atheroscler Suppl; 2013 Aug; 14(2):243-51. PubMed ID: 23958480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants.
    Hoang T; Kim J
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE
    J Am Heart Assoc; 2019 Oct; 8(19):e013543. PubMed ID: 31567003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis.
    Popoff F; Balaciano G; Bardach A; Comandé D; Irazola V; Catalano HN; Izcovich A
    BMC Cardiovasc Disord; 2019 Jun; 19(1):136. PubMed ID: 31164089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis.
    Enns JE; Yeganeh A; Zarychanski R; Abou-Setta AM; Friesen C; Zahradka P; Taylor CG
    BMC Cardiovasc Disord; 2014 May; 14():70. PubMed ID: 24885361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Kwak SM; Myung SK; Lee YJ; Seo HG;
    Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
    Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation-A Meta-Regression of Randomized Trials.
    Sethi A; Bajaj A; Khosla S; Arora RR
    Am J Ther; 2016; 23(3):e737-48. PubMed ID: 25036814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of omega-3 fatty acid on major cardiovascular outcomes: A systematic review and meta-analysis.
    Yu F; Qi S; Ji Y; Wang X; Fang S; Cao R
    Medicine (Baltimore); 2022 Jul; 101(30):e29556. PubMed ID: 35905212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
    Lee IM; Cook NR; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
    JAMA; 2005 Jul; 294(1):56-65. PubMed ID: 15998891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.
    Chen Q; Cheng LQ; Xiao TH; Zhang YX; Zhu M; Zhang R; Li K; Wang Y; Li Y
    Cardiovasc Drugs Ther; 2011 Jun; 25(3):259-65. PubMed ID: 21626218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.